Comparison of Cellular Death Pathways after mTHPC-mediated Photodynamic Therapy (PDT) in Five Human Cancer Cell Lines

One of the most promising photosensitizers (PS) used in photodynamic therapy (PDT) is the porphyrin derivative 5,10,15,20-tetra(<i>m</i>-hydroxyphenyl)chlorin (mTHPC, temoporfin), marketed in Europe under the trade name Foscan<sup>&#174;</sup>. A set of five human cancer...

Full description

Bibliographic Details
Main Authors: Carsten Lange, Christiane Lehmann, Martin Mahler, Patrick J. Bednarski
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/11/5/702
id doaj-1e909a4f47234566b65a33b305d38ed7
record_format Article
spelling doaj-1e909a4f47234566b65a33b305d38ed72020-11-24T21:28:56ZengMDPI AGCancers2072-66942019-05-0111570210.3390/cancers11050702cancers11050702Comparison of Cellular Death Pathways after mTHPC-mediated Photodynamic Therapy (PDT) in Five Human Cancer Cell LinesCarsten Lange0Christiane Lehmann1Martin Mahler2Patrick J. Bednarski3Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, Friedrich-Ludwig-Jahn-Straße 17, 17489 Greifswald, GermanyDepartment of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, Friedrich-Ludwig-Jahn-Straße 17, 17489 Greifswald, GermanyDepartment of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, Friedrich-Ludwig-Jahn-Straße 17, 17489 Greifswald, GermanyDepartment of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, Friedrich-Ludwig-Jahn-Straße 17, 17489 Greifswald, GermanyOne of the most promising photosensitizers (PS) used in photodynamic therapy (PDT) is the porphyrin derivative 5,10,15,20-tetra(<i>m</i>-hydroxyphenyl)chlorin (mTHPC, temoporfin), marketed in Europe under the trade name Foscan<sup>&#174;</sup>. A set of five human cancer cell lines from head and neck and other PDT-relevant tissues was used to investigate oxidative stress and underlying cell death mechanisms of mTHPC-mediated PDT in vitro. Cells were treated with mTHPC in equitoxic concentrations and illuminated with light doses of 1.8&#8722;7.0 J/cm<sup>2</sup> and harvested immediately, 6, 24, or 48 h post illumination for analyses. Our results confirm the induction of oxidative stress after mTHPC-based PDT by detecting a total loss of mitochondrial membrane potential (&#916;<i>&#968;</i><sub>m</sub>) and increased formation of ROS. However, lipid peroxidation (LPO) and loss of cell membrane integrity play only a minor role in cell death in most cell lines. Based on our results, apoptosis is the predominant death mechanism following mTHPC-mediated PDT. Autophagy can occur in parallel to apoptosis or the former can be dominant first, yet ultimately leading to autophagy-associated apoptosis. The death of the cells is in some cases accompanied by DNA fragmentation and a G<sub>2</sub>/M phase arrest. In general, the overall phototoxic effects and the concentrations as well as the time to establish these effects varies between cell lines, suggesting that the cancer cells are not all dying by one defined mechanism, but rather succumb to an individual interplay of different cell death mechanisms. Besides the evaluation of the underlying cell death mechanisms, we focused on the comparison of results in a set of five identically treated cell lines in this study. Although cells were treated under equitoxic conditions and PDT acts via a rather unspecific ROS formation, very heterogeneous results were obtained with different cell lines. This study shows that general conclusions after PDT in vitro require testing on several cell lines to be reliable, which has too often been ignored in the past.https://www.mdpi.com/2072-6694/11/5/702mTHPCphotodynamic therapyoxidative stressnecrosisapoptosisautophagycell cycle
collection DOAJ
language English
format Article
sources DOAJ
author Carsten Lange
Christiane Lehmann
Martin Mahler
Patrick J. Bednarski
spellingShingle Carsten Lange
Christiane Lehmann
Martin Mahler
Patrick J. Bednarski
Comparison of Cellular Death Pathways after mTHPC-mediated Photodynamic Therapy (PDT) in Five Human Cancer Cell Lines
Cancers
mTHPC
photodynamic therapy
oxidative stress
necrosis
apoptosis
autophagy
cell cycle
author_facet Carsten Lange
Christiane Lehmann
Martin Mahler
Patrick J. Bednarski
author_sort Carsten Lange
title Comparison of Cellular Death Pathways after mTHPC-mediated Photodynamic Therapy (PDT) in Five Human Cancer Cell Lines
title_short Comparison of Cellular Death Pathways after mTHPC-mediated Photodynamic Therapy (PDT) in Five Human Cancer Cell Lines
title_full Comparison of Cellular Death Pathways after mTHPC-mediated Photodynamic Therapy (PDT) in Five Human Cancer Cell Lines
title_fullStr Comparison of Cellular Death Pathways after mTHPC-mediated Photodynamic Therapy (PDT) in Five Human Cancer Cell Lines
title_full_unstemmed Comparison of Cellular Death Pathways after mTHPC-mediated Photodynamic Therapy (PDT) in Five Human Cancer Cell Lines
title_sort comparison of cellular death pathways after mthpc-mediated photodynamic therapy (pdt) in five human cancer cell lines
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2019-05-01
description One of the most promising photosensitizers (PS) used in photodynamic therapy (PDT) is the porphyrin derivative 5,10,15,20-tetra(<i>m</i>-hydroxyphenyl)chlorin (mTHPC, temoporfin), marketed in Europe under the trade name Foscan<sup>&#174;</sup>. A set of five human cancer cell lines from head and neck and other PDT-relevant tissues was used to investigate oxidative stress and underlying cell death mechanisms of mTHPC-mediated PDT in vitro. Cells were treated with mTHPC in equitoxic concentrations and illuminated with light doses of 1.8&#8722;7.0 J/cm<sup>2</sup> and harvested immediately, 6, 24, or 48 h post illumination for analyses. Our results confirm the induction of oxidative stress after mTHPC-based PDT by detecting a total loss of mitochondrial membrane potential (&#916;<i>&#968;</i><sub>m</sub>) and increased formation of ROS. However, lipid peroxidation (LPO) and loss of cell membrane integrity play only a minor role in cell death in most cell lines. Based on our results, apoptosis is the predominant death mechanism following mTHPC-mediated PDT. Autophagy can occur in parallel to apoptosis or the former can be dominant first, yet ultimately leading to autophagy-associated apoptosis. The death of the cells is in some cases accompanied by DNA fragmentation and a G<sub>2</sub>/M phase arrest. In general, the overall phototoxic effects and the concentrations as well as the time to establish these effects varies between cell lines, suggesting that the cancer cells are not all dying by one defined mechanism, but rather succumb to an individual interplay of different cell death mechanisms. Besides the evaluation of the underlying cell death mechanisms, we focused on the comparison of results in a set of five identically treated cell lines in this study. Although cells were treated under equitoxic conditions and PDT acts via a rather unspecific ROS formation, very heterogeneous results were obtained with different cell lines. This study shows that general conclusions after PDT in vitro require testing on several cell lines to be reliable, which has too often been ignored in the past.
topic mTHPC
photodynamic therapy
oxidative stress
necrosis
apoptosis
autophagy
cell cycle
url https://www.mdpi.com/2072-6694/11/5/702
work_keys_str_mv AT carstenlange comparisonofcellulardeathpathwaysaftermthpcmediatedphotodynamictherapypdtinfivehumancancercelllines
AT christianelehmann comparisonofcellulardeathpathwaysaftermthpcmediatedphotodynamictherapypdtinfivehumancancercelllines
AT martinmahler comparisonofcellulardeathpathwaysaftermthpcmediatedphotodynamictherapypdtinfivehumancancercelllines
AT patrickjbednarski comparisonofcellulardeathpathwaysaftermthpcmediatedphotodynamictherapypdtinfivehumancancercelllines
_version_ 1725968460099354624